{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:17Z","timestamp":1793082797576,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179414","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:08:21Z","timestamp":1791904101000},"page":"179414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antidepressants and cognitive function in major depressive disorder: Mechanisms, clinical evidence, and implications for precision treatment"],"prefix":"10.1016","volume":"1037","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4134-1493","authenticated-orcid":false,"given":"Yao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-4067","authenticated-orcid":false,"given":"Yunfei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179414_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jad.2019.11.028","article-title":"Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression","volume":"263","author":"Acevedo-Diaz","year":"2020","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1037\/neu0000319","article-title":"Cognitive functioning in the first-episode of major depressive disorder: a systematic review and meta-analysis","volume":"31","author":"Ahern","year":"2017","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1176\/appi.ajp.20230392","article-title":"Cognitive outcomes after antidepressant pharmacotherapy for late-life depression: a systematic review and meta-analysis","volume":"181","author":"Ainsworth","year":"2024","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pnpbp.2018.08.004","article-title":"Functional MRI findings, pharmacological treatment in major depression and clinical response","volume":"91","author":"Arnone","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archgenpsychiatry.2011.1481","article-title":"Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia","volume":"69","author":"Barnes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psyneuen.2013.12.004","article-title":"HPA axis and aging in depression: systematic review and meta-analysis","volume":"41","author":"Belvederi Murri","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/ph18060867","article-title":"Unveiling the anti-inflammatory effects of antidepressants: a systematic review of human studies over the last decade","volume":"18","author":"Bleibel","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archpsyc.61.6.587","article-title":"The nature and determinants of neuropsychological functioning in late-life depression","volume":"61","author":"Butters","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-017-0847-z","article-title":"Antidepressant use and cognitive decline in community-dwelling elderly people - the Three-City Cohort","volume":"15","author":"Carri\u00e8re","year":"2017","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40263-021-00793-1","article-title":"Cognitive outcomes with sequential escitalopram monotherapy and adjunctive aripiprazole treatment in major depressive disorder: a Canadian biomarker integration network in depression (CAN-BIND-1) report","volume":"35","author":"Chakrabarty","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.179414_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","article-title":"Brain-gut-microbiota axis in depression: a historical overview and future directions","volume":"182","author":"Chang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2026.179414_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122815","article-title":"Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder","volume":"351","author":"Chen","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179414_bib12","article-title":"Disorganization of white matter architecture in major depressive disorder: a meta-analysis of diffusion tensor imaging with tract-based spatial statistics","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179414_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2019.04.024","article-title":"A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: a pilot randomized controlled trial at a single-center in China","volume":"114","author":"Chen","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2026.179414_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jad.2017.09.008","article-title":"Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: a randomized control study","volume":"225","author":"Chen","year":"2018","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/nn.3470","article-title":"Multi-task connectivity reveals flexible hubs for adaptive task control","volume":"16","author":"Cole","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/da.20060","article-title":"Effects of sertraline on depressive symptoms and attentional and executive functions in major depression","volume":"21","author":"Constant","year":"2005","journal-title":"Depress Anxiety"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/JGP.0b013e3181b4bf4a","article-title":"Change in cognitive functioning following acute antidepressant treatment in late-life depression","volume":"17","author":"Culang","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179414_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/gps.2783","article-title":"Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline","volume":"27","author":"Culang-Reinlieb","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12888-022-03789-3","article-title":"Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review","volume":"22","author":"Dai","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"Suppl 6","key":"10.1016\/j.ejphar.2026.179414_bib21","first-page":"7","article-title":"Depression: the case for a monoamine deficiency","volume":"61","author":"Delgado","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179414_bib22","doi-asserted-by":"crossref","first-page":"M1137","DOI":"10.1093\/gerona\/58.12.M1137","article-title":"Does antidepressant therapy improve cognition in elderly depressed patients?","volume":"58","author":"Doraiswamy","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib24","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1038\/s41380-025-03085-y","article-title":"Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research","volume":"30","author":"Feng","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/11586580-000000000-00000","article-title":"Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study","volume":"28","author":"Fortin","year":"2011","journal-title":"Drugs Aging"},{"issue":"17","key":"10.1016\/j.ejphar.2026.179414_bib26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s40265-016-0655-3","article-title":"Vortioxetine: a review in cognitive dysfunction in depression","volume":"76","author":"Frampton","year":"2016","journal-title":"Drugs"},{"issue":"2-3","key":"10.1016\/j.ejphar.2026.179414_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2006.01.018","article-title":"Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy","volume":"91","author":"Gallassi","year":"2006","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00213-005-0274-2","article-title":"Cognitive performance in depressed patients after chronic use of antidepressants","volume":"185","author":"Gorenstein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psychres.2014.12.004","article-title":"Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion","volume":"225","author":"Gorlyn","year":"2015","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejphar.2026.179414_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fpsyt.2018.00382","article-title":"A systematic review of cognitive predictors of treatment outcome in major depression","volume":"9","author":"Groves","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.764374","article-title":"Cognitive impairment and neurocognitive profiles in major Depression-A clinical perspective","volume":"13","author":"Hammar","year":"2022","journal-title":"Front Psychiatry"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib33","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00406-023-01570-5","article-title":"Arketamine for cognitive impairment in psychiatric disorders","volume":"273","author":"Hashimoto","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.ejphar.2026.179414_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.pbr.2023.01.003","article-title":"Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression","volume":"278","author":"Hashimoto","year":"2023","journal-title":"Prog. Brain Res."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib35","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41380-023-02287-6","article-title":"Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions","volume":"28","author":"Hashimoto","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.65801\/pcp.3512","article-title":"Therapeutic potential of classical psychedelics and NonHallucinogenic psychoplastogens in psychiatric disorders","volume":"36","author":"Hashimoto","year":"2026","journal-title":"Psychiatry and Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jatmed.2024.07.001","article-title":"Ketamine and its two enantiomers in anesthesiology and psychiatry: a historical review and future directions","volume":"3","author":"Hashimoto","year":"2024","journal-title":"J Anesth Transl Med"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179414_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3390\/biom12101464","article-title":"A bibliometric analysis of research on the role of BDNF in depression and treatment","volume":"12","author":"He","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpsychires.2008.10.015","article-title":"Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder","volume":"43","author":"Herrera-Guzm\u00e1n","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.psychres.2007.04.012","article-title":"Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder","volume":"160","author":"Herrera-Guzm\u00e1n","year":"2008","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2009.06.023","article-title":"Cognitive impairment in major depression: association with salivary cortisol","volume":"66","author":"Hinkelmann","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/gps.1951","article-title":"A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression","volume":"23","author":"Holtzheimer","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2024.09.001","article-title":"Assessing the efficacy and safety of combined buspirone and venlafaxine treatment in late-life depression accompanied by cognitive impairment: a randomized controlled trial","volume":"91","author":"Hu","year":"2024","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib45","article-title":"Potentially inappropriate medication: association between the use of antidepressant drugs and the subsequent risk for dementia","volume":"226","author":"K","year":"2018","journal-title":"Journal of affective disorders"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","article-title":"Large-Scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity","volume":"72","author":"Kaiser","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179414_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S2215-0366(16)00095-X","article-title":"Treating cognitive impairment in depression: an unmet need","volume":"3","author":"Keefe","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archgenpsychiatry.2011.60","article-title":"Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder","volume":"68","author":"Kempton","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00213-006-0428-x","article-title":"The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine","volume":"187","author":"Kern","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"1-2","key":"10.1016\/j.ejphar.2026.179414_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2008.11.020","article-title":"Antidepressants and dementia","volume":"117","author":"Kessing","year":"2009","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib53","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1038\/s41380-024-02551-3","article-title":"Gut microbiome predicts cognitive function and depressive symptoms in late life","volume":"29","author":"Kolobaric","year":"2024","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib54","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S1355617724000262","article-title":"Anxiety in late-life depression is associated with poorer performance across multiple cognitive domains","volume":"30","author":"Kryza-Lacombe","year":"2024","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.ejphar.2026.179414_bib55","article-title":"Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning?","volume":"2012","author":"Lam","year":"2012","journal-title":"Depress Res Treat"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.10m06176blu","article-title":"Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA)","volume":"72","author":"Lamers","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jad.2020.12.195","article-title":"Risk of incident dementia varies with different onset and courses of depression","volume":"282","author":"Lee","year":"2021","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"10248","key":"10.1016\/j.ejphar.2026.179414_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.179414_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2022.08.129","article-title":"Disorder-specific impaired neurocognitive function in major depression and generalized anxiety disorder","volume":"318","author":"Luo","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ejphar.2026.179414_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2024.11.023","article-title":"The vagus nerve: an old but new player in brain-body communication","volume":"124","author":"Ma","year":"2025","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179414_bib62","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, Placebo-Controlled, Active-Reference, Double-Blind, flexible-dose Study of the efficacy of Vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179414_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/neu.2023.6","article-title":"Apathy associated with antidepressant drugs: a systematic review","volume":"35","author":"Masdrakis","year":"2023","journal-title":"Acta Neuropsychiatr."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib64","doi-asserted-by":"crossref","first-page":"ITC65","DOI":"10.7326\/AITC202105180","article-title":"Depression","volume":"174","author":"McCarron","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib65","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2026.179414_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113993","article-title":"The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: results from the Canadian rapid treatment center of excellence (CRTCE)","volume":"302","author":"McIntyre","year":"2021","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpsychires.2009.07.012","article-title":"The impact of treatment on HPA axis activity in unipolar major depression","volume":"44","author":"McKay","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12916-025-03851-3","article-title":"Antidepressant use and cognitive decline in patients with dementia: a national cohort study","volume":"23","author":"Mo","year":"2025","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib70","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.ejphar.2026.179414_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae046","article-title":"Effect of Esketamine Nasal spray on cognition in patients with treatment-resistant depression: results from four phase 3 studies","volume":"27","author":"Morrison","year":"2024","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2026.179414_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2026.106720","article-title":"A critical review of brain entropy as a biomarker of the psychedelic state","volume":"186","author":"Moses","year":"2026","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179414_bib73","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/nu16091352","article-title":"Effectiveness of psychobiotics in the treatment of psychiatric and cognitive disorders: a systematic review of randomized clinical trials","volume":"16","author":"Mosquera","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2026.179414_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106209","article-title":"Demyelination in psychiatric and neurological disorders: mechanisms, clinical impact, and novel therapeutic strategies","volume":"174","author":"Murayama","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ejphar.2026.179414_bib75","doi-asserted-by":"crossref","unstructured":"Murrough JW, Wan LB, Iacoviello B, et al. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology (Berl). Published online September 11, 2013. doi:10.1007\/s00213-013-3255-x.","DOI":"10.1007\/s00213-013-3255-x"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib76","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41593-020-0621-y","article-title":"Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons","volume":"23","author":"Nagy","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179414_bib77","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1176\/ajp.154.11.1497","article-title":"DST studies in psychotic depression: a meta-analysis","volume":"154","author":"Nelson","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jagp.2024.08.015","article-title":"A systematic review of antidepressants and psychotherapy commonly used in the treatment of late life depression for their effects on cognition","volume":"33","author":"Nelson","year":"2025","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib79","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.916041","article-title":"Prediction of antidepressant efficacy by cognitive function in first-episode late-life depression: a pilot Study","volume":"13","author":"Pan","year":"2022","journal-title":"Front Psychiatry"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib81","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00213-016-4206-0","article-title":"Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats","volume":"233","author":"Papp","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib83","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/gps.4375","article-title":"Combined treatment with memantine\/es-citalopram for older depressed patients with cognitive impairment: a pilot study","volume":"31","author":"Pelton","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib82","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/gps.1958","article-title":"Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study","volume":"23","author":"Pelton","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib84","article-title":"Immuno-metabolic depression: from concept to implementation","volume":"48","author":"Penninx","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179414_bib86","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv037","article-title":"A prospective, longitudinal Study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression","volume":"18","author":"Phillips","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179414_bib87","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/ijnp\/pyac045","article-title":"Assessment of objective and subjective cognitive function in patients with treatment-resistant depression undergoing repeated ketamine infusions","volume":"25","author":"Phillips","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/appi.ajp.2014.14010076","article-title":"Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches","volume":"172","author":"Phillips","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jagp.2015.05.010","article-title":"A meta-analysis of executive dysfunction and antidepressant treatment response in late-life depression","volume":"24","author":"Pimontel","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jpsychires.2015.04.010","article-title":"Oligodendrocyte morphometry and expression of myelin - related mRNA in ventral prefrontal white matter in major depressive disorder","volume":"65","author":"Rajkowska","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib90","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial","volume":"164","author":"Raskin","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib91","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0269881116631649","article-title":"The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial","volume":"30","author":"Reddy","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/jpn.180243","article-title":"Time heals all wounds? A 2-year longitudinal diffusion tensor imaging study in major depressive disorder","volume":"44","author":"Repple","year":"2019","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jagp.2013.01.019","article-title":"Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo","volume":"22","author":"Robinson","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib94","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4088\/JCP.v66n0313","article-title":"Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial","volume":"66","author":"Rocca","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv082","article-title":"The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"19","author":"Rosenblat","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib96","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","article-title":"Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe","volume":"74","author":"Ruscio","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib97","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41598-017-02062-y","article-title":"Myelination of the brain in Major Depressive Disorder: an in vivo quantitative magnetic resonance imaging study","volume":"7","author":"Sacchet","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.amjmed.2015.01.007","article-title":"Antidepressant use and cognitive decline: the health and retirement Study","volume":"128","author":"Saczynski","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.ejphar.2026.179414_bib99","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jad.2020.01.149","article-title":"Pharmacological management of depression: japanese expert consensus","volume":"266","author":"Sakurai","year":"2020","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.rpsm.2017.06.006","article-title":"Vortioxetine: a new alternative for the treatment of major depressive disorder","volume":"11","author":"Salagre","year":"2018","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"key":"10.1016\/j.ejphar.2026.179414_bib101","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib102","first-page":"14","article-title":"SSRI-Induced indifference","volume":"7","author":"Sansone","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib103","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S1461145707007997","article-title":"Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients","volume":"11","author":"Savaskan","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib105","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/mp.2016.60","article-title":"Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group","volume":"22","author":"Schmaal","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179414_bib104","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib106","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000205516","article-title":"Psychomotor changes in major depressive disorder during sertraline treatment","volume":"59","author":"Schrijvers","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179414_bib107","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neubiorev.2007.12.002","article-title":"The role of the amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies","volume":"32","author":"Sergerie","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib108","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2215-0366(16)00012-2","article-title":"Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study","volume":"3","author":"Shilyansky","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.ejphar.2026.179414_bib109","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S1461145714001011","article-title":"Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression","volume":"17","author":"Shiroma","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2026.179414_bib110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jad.2020.08.058","article-title":"Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression","volume":"277","author":"Shiroma","year":"2020","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib111","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40261-022-01169-z","article-title":"A systematic review of neurocognitive effects of subanesthetic doses of intravenous ketamine in major depressive disorder, post-traumatic stress disorder, and healthy population","volume":"42","author":"Shiroma","year":"2022","journal-title":"Clin Drug Investig"},{"issue":"1-2","key":"10.1016\/j.ejphar.2026.179414_bib112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.psychres.2014.06.053","article-title":"The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial","volume":"220","author":"Soczynska","year":"2014","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib113","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/0269881120944152","article-title":"Risk of incident dementia in late-life depression treated with antidepressants: a nationwide population cohort study","volume":"34","author":"Su","year":"2020","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib114","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2478\/v10039-010-0053-0","article-title":"Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study","volume":"55","author":"Talarowska","year":"2010","journal-title":"Adv Med Sci"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179414_bib116","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00406-021-01365-6","article-title":"Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling","volume":"272","author":"Tan","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.ejphar.2026.179414_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172839","article-title":"Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: role of BDNF-TrkB signaling","volume":"188","author":"Tan","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179414_bib117","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejphar.2026.179414_bib118","article-title":"Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179414_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-019-00854-w","article-title":"Targeting hormones for improving cognition in major mood disorders and schizophrenia: thyroid hormones and Prolactin","volume":"40","author":"Tost","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ejphar.2026.179414_bib120","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jad.2017.11.053","article-title":"The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: a short-term, randomized, double-blind, exploratory study versus escitalopram","volume":"227","author":"Vieta","year":"2018","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179414_bib121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1192\/bjp.2023.148","article-title":"Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials","volume":"224","author":"Vreijling","year":"2024","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1749-6632.2009.04416.x","article-title":"The role of sleep in cognition and emotion","volume":"1156","author":"Walker","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib123","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/WAD.0000000000000103","article-title":"Antidepressant use in the elderly is associated with an increased risk of dementia","volume":"30","author":"Wang","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"19","key":"10.1016\/j.ejphar.2026.179414_bib125","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.3390\/jcm12196342","article-title":"Association between antidepressants and dementia risk in older adults with depression: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib124","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4068\/cmj.2018.54.2.101","article-title":"Addressing the side effects of contemporary antidepressant drugs: a comprehensive review","volume":"54","author":"Wang","year":"2018","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.ejphar.2026.179414_bib126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jad.2023.10.038","article-title":"Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: a randomized controlled trial","volume":"344","author":"Wang","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ejphar.2026.179414_bib127","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","article-title":"Brain-spleen axis in health and diseases: a review and future perspective","volume":"182","author":"Wei","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2026.179414_bib129","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jad.2024.08.222","article-title":"Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: a role of transforming growth factor-\u03b21","volume":"367","author":"Xu","year":"2024","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179414_bib128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s13311-023-01362-8","article-title":"Interactions between antidepressants and intestinal microbiota","volume":"20","author":"Xu","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2026.179414_bib130","article-title":"Relationship between immunometabolic status and cognitive performance among major depression disorder patients","volume":"137","author":"Y","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179414_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.95","article-title":"Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179414_bib132","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/1570159X14666160119094646","article-title":"Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets","volume":"14","author":"Zhang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2026.179414_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177096","article-title":"Transforming growth factor-\u03b21 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice","volume":"985","author":"Zhao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179414_bib134","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-026-03590-8","article-title":"Pleiotropic modulation of the gut-brain-lung axis by ketamine and its enantiomers","author":"Zhao","year":"2026","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179414_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116287","article-title":"Rumination and the default mode network: Meta-analysis of brain imaging studies and implications for depression","volume":"206","author":"Zhou","year":"2020","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179414_bib136","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad177","article-title":"Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis","volume":"46","author":"Zhou","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.ejphar.2026.179414_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111228","article-title":"Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-\u03b21 activation","volume":"136","author":"Zhu","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179414_bib138","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpsychires.2003.12.002","article-title":"Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment","volume":"38","author":"Zobel","year":"2004","journal-title":"J. Psychiatr. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:37:37Z","timestamp":1793079457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":138,"alternative-id":["S0014299926008964"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179414","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressants and cognitive function in major depressive disorder: Mechanisms, clinical evidence, and implications for precision treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179414"}}